Scipher Medicine
PrivateLast Round
Series D
Extension
Jul 30, 2024
Est. Valuation
$490M
Total Funding Raised
$232.85M
Company Overview
Scipher Medicine is a biotechnology company that offers a precision medicine platform to identify the most effective drug for patients with autoimmune diseases based on their unique biological profiles and molecular signature tests.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Drug Discovery, Medical AI, Biotechnology
Business Model
B2B2C
Customer Profile
Services & Consulting, Data as a Service, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Scipher Medicine Comps
Public and private peers based on sector, stage, and business model.
Scipher Medicine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Jul 30, 2024 | ||||
| Series D | Feb 24, 2022 | ||||
| Series C | Mar 24, 2021 | ||||
| Series B | Feb 19, 2020 | ||||
| Series A | Sep 6, 2018 |
Key People
Founding team and executive leadership
Scipher Medicine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Granpool Innovative Investments | Series B, Seed |
| Kaiser Permanente Ventures | Series B |
| Khosla Ventures | Series B, Series C, Series D, Series A |
| TD Securities | Series D |
| Neuberger Berman | Series D |
| Optum Ventures | Series D, Series B |
| Eco Innovation Alliance | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2025
Partnered with InnoSIGN Inc. to analyze immune-mediated diseases.
Scipher Medicine Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Scipher Medicine's valuation, stock price, and market status.
